Acorda will receive a royalty from Watson based on product sales. Additional terms of the agreement have not been disclosed. Tizanidine hydrochloride capsule is a short-acting drug indicated
Synchroneuron co-founder and CSO Fogel said they aim to bring relief to millions of patients with TD and other movement disorders by developing novel therapies. The company plans
NRL-1 is a proprietary formulation of diazepam delivered via a commercially available nasal sprayer, and is being developed for the management of patients who require intermittent use of
The approval is based on data from clinical studies, which have assessed the efficacy and tolerability of vildagliptin as monotherapy. According to the study data, vildagliptin showed significant
Edarbyclor is a fixed-dose combination of two medications: azilsartan medoxomil, an angiotensin II receptor blocker (ARB), and chlorthalidone, a long-acting diuretic used in the treatment of hypertension. In
The company’s Boronia site manufactures sterile and non-sterile liquid products utilizing ‘blow-fill-seal’ (BFS) technology for conditions such as migraine, herpes, epilepsy, smoking cessation, hypertension, asthma, pain relief and
After the acquisition, Shanghai will allow Kony Pharma to enhance its EHS management system and step up its efforts in international certification. Kony Pharma can leverage on relationships
GSK has identified microbiological finding in a small number of patients in the Phase IIb trial of GSK ‘052 for the treatment of complicated urinary tract infections (cUTI).
Scenesse’s MAA covers its use as a prophylactic treatment in adult patients with erythropoietic protoporphyria (EPP), a disease causing absolute intolerance of patients’ skin to light. Scenesse is
Palifosfamide (Zymafos or ZIO-201) is a novel DNA cross-linker that in preclinical study has shown to bypass resistance mediated by aldehyde dehydrogenase (ALDH), in addition to conferring a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.